This is a prospective study using \[68Ga\]Ga DOTA-5G PET/CT imaging in patients diagnosed with metastatic/advanced invasive lobular breast cancer (LBC).
(Ability to understand and willingness to sign a written informed consent document.
Men and women age ≥ 18 yrs
Confirmed presence of metastatic/advanced invasive lobular breast cancer and measurable disease per RECIST (version 1.1) or PERCIST
Available archival tumor tissue
Pregnant and lactating women
Prisoners
Concurrent malignancy of a different histology that could confound imaging interpretation.
Patients who cannot undergo PET/CT scanning because of weight limits(>350lbs)
University of California, Davis
Lead sponsor
Dr. Helen K Chew, University of California Davis
Collaborator
Dr. Cameron Foster, University of California Davis
Collaborator
Society of Nuclear Medicine and Molecular Imaging
Collaborator